2023

Wikoff D, Ring C, DeVito M, Walker N, Birnbaum L, Haws L. 2023. Development and application of a systematic and quantitative weighting framework to evaluate the quality and relevance of relative potency estimates for dioxin-like compounds (DLCs) for human health risk assessment. Regul Toxicol Pharmacol 145:105500; doi: 10.1016/j.yrtph.2023.105500. PMID: 37866700.

View Abstract

Perry CS, Blanchette AD, Vivanco SN, Verwiel AH, Proctor DM. 2023. Use of physiologically based pharmacokinetic modeling to support development of an acute (24-hour) health-based inhalation guideline for manganese. Regul Toxicol Pharmacol 145:105518; doi: 10.1016/j.yrtph.2023.105518. PMID: 3786341.

View Abstract

Thompson CM, Kirman C, Harris MA. 2023. Derivation of oral cancer slope factors for hexavalent chromium informed by pharmacokinetic models and in vivo genotoxicity data. Regul Toxicol Pharmacol 145(Dec):105521; doi: 10.1016/j.yrtph.2023.105521. PMID: 37863416.

View Abstract

Heintz M, Thompson C, Fitch S, Rogers S, Wikoff D, Haws L, Rivera B. 2023. Protocol to develop updated oral toxicity values for HFPO-DA. OSF | Protocol_Oct2023.pdf.

Henderson RG, Vincent M, Rivera BN, Bonn-Miller MO, Doepker C. 2023. Cannabidiol safety considerations: Development of a potential acceptable daily intake value and recommended upper intake limits for dietary supplement use. Regul Toxicol Pharmacol 144(Oct):105482; doi: 10.1016/j.yrtph.2023.105482. PMID: 37634699.

View Abstract

Kulpa J, Lefever TW, Trexler KR, Henderson RG, MacNair L, Toth ML, Vanapalli SA, Rahman M, Gupta S, Bonn-Miller MO. 2023. Toxicity of cannabigerol: Examination of long-term toxicity and lifespan in Caenorhabditis elegans and 14-day study in Sprague Dawley rats. Cannabis Cannabinoid Res 8(S1):S62–S70; doi: 10.1089/can.2023.0035.

View Abstract

Kulpa J, Henderson RG, Schwotzer D, Dye W, Trexler KR, McDonald J, Lefever TW, Bonn-Miller MO. 2023. Toxicological evaluation and pain assessment of four minor cannabinoids following 14-day oral administration in rats. Cannabis Cannabinoid Res 8(S1):S25–S41 doi: 10.1089/can.2023.0049. PMID: 37721989.

View Abstract

Wharton GT, Becker C, Bennett D, Burcu M, Bushnell G, …, Movva N, …, Suh M, et al. Overview of global real world data sources for pediatric pharmacoepidemiological research. Poster 217, International Society for Pharmacoepidemiology (ICPE) annual meeting, Halifax, Nova Scotia, August 2023.

View Abstract

Bowden A, Escher S, Rose J, Sadekar N, Patlewicz G, O’Keeffe L, Bury D, Hewitt NJ, et al. 2023. Workshop report: Challenges faced in developing inhalation thresholds of Toxicological Concern (TTC) – State of the science and next steps. Regul Toxicol Pharmacol 142(Aug):105434; doi: 10.1016/j.yrtph.2023.105434. PMID: 37302561.

View Abstract

Pastula S, Suh M, Jiang X, Reichert H, Movva N, Fryzek J, Simões EAF. Respiratory syncytial virus (RSV) and bronchiolitis epidemiology among the United States infant Medicaid populations in seven states. Poster 191, International Society for Pharmacoepidemiology (ICPE) annual meeting, Halifax, Nova Scotia, August 2023.

View Abstract